Nathan Caffo - Jul 26, 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Business Officer
Signature
/s/ Nathan Caffo
Stock symbol
CADL
Transactions as of
Jul 26, 2021
Transactions value $
$0
Form type
3
Date filed
7/26/2021, 09:18 PM
Next filing
Aug 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CADL Stock Option (Right to Buy) Jul 26, 2021 Common Stock 296K $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on September 24, 2021, with the remainder vesting in 36 substantially equal monthly installment thereafter.